We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.

Arenas, M., Selek, U., Kaidar-Person, O., Perrucci, E., Montero Luis, A., Boersma, L., Coles, C., Offersen, B., Meattini, I., Bolukbasi, Y., Leonardi, M. C., Pfeffer, R., Cutuli, B., Vidali, C., Franco, P., Kouloulias, V., Masiello, V., Rivera, S., Bourgier, C., Ciabattoni, A., Lancellotta, V., Trigo, L., Valentini, V., Poortmans, P., Aristei, C., The 2018 assisi think tank meeting on breast cancer: International expert panel white paper, <<CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY>>, 2020; 151 (luglio): N/A-N/A. [doi:10.1016/j.critrevonc.2020.102967] [http://hdl.handle.net/10807/207142]

The 2018 assisi think tank meeting on breast cancer: International expert panel white paper

Vidali, C.;Ciabattoni, A.;Valentini, V.;Aristei, C.
2020

Abstract

We report on the second Assisi Think Tank Meeting (ATTM) on breast cancer which was held under the auspices of the European Society for RadioTherapy & Oncology (ESTRO). In discussing in-depth current evidence and practice it was designed to identify grey areas in diverse forms of the disease. It aimed at addressing uncertainties and proposing future trials to improve patient care. Before the meeting, three key topics were selected: 1) primary systemic therapy, mastectomy, breast reconstruction and post-mastectomy radiation therapy, 2) therapeutic options in ductal carcinoma in situ, and 3) therapy de-escalation in early stage breast cancer. Clinical practice in these areas was investigated by means of an online questionnaire. The time lapse period between the survey and the meeting was used to review the literature and on-going clinical trials. At the ATTM both were discussed in depth and research protocols were proposed.
Inglese
Arenas, M., Selek, U., Kaidar-Person, O., Perrucci, E., Montero Luis, A., Boersma, L., Coles, C., Offersen, B., Meattini, I., Bolukbasi, Y., Leonardi, M. C., Pfeffer, R., Cutuli, B., Vidali, C., Franco, P., Kouloulias, V., Masiello, V., Rivera, S., Bourgier, C., Ciabattoni, A., Lancellotta, V., Trigo, L., Valentini, V., Poortmans, P., Aristei, C., The 2018 assisi think tank meeting on breast cancer: International expert panel white paper, <<CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY>>, 2020; 151 (luglio): N/A-N/A. [doi:10.1016/j.critrevonc.2020.102967] [http://hdl.handle.net/10807/207142]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/207142
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact